TTrialPathMatch Me to Trials
← Back to trials
RecruitingEosinophilic Gastrointestinal Disorders (EGIDs)Eosinophilic EsophagitisEosinophilic Gastritis

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

Eligible age

3+ yrs

Accepts

All genders

Locations

16 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this observational study is to find the best measures to define how well a person with eosinophilic disorder is doing. People with EoE, EoG, EoN and EoC normally undergo endoscopy and/or colonoscopy where cells are collected for microscopic analysis. Treatments are then decided based on how the cells look. We are aiming to compare different tissue components such as inflammatory cell types with clinical symptoms. We want to see if scores on standard questionnaires can give us an idea how well the person is doing.

Sponsor: Children's Hospital Medical Center, Cincinnati

You may qualify if…

  • Males or females 3 years of age and older
  • Mucosal eosinophilia:
  • EoE ≥ 15 eosinophils/HPF in the distal or proximal esophagus EoG ≥ 30 eosinophils/HPF in 5 HPF\'s in the body and/or antrum EoN ≥ 53 eosinophils/HPF in the duodenum and/or ≥ 56 eosinophils/HPF in the jejunum and/or ileum EoC ≥ 84 eosinophils/HPF from the transverse or descending colon and/or ≥ 32 eosinophils/HPF from the rectosigmoid colon or a biopsy from any colonic location with ≥ 100 eosinophils/HPF
  • \- Presence of symptoms is required for patients who are newly diagnosed but not required for patients who were previously diagnosed.

You may not qualify if…

  • History of intestinal surgery other than G tube placement
  • Enrolled in a blinded investigational study at the time of the first study visit
  • Have esophageal stricture (\<3mm)
  • Have other identifiable causes for eosinophilia (except Inflammatory Bowel Disease): infections, Gastrointestinal (GI) cancer, other GI inflammatory disease (e.g., Ulcerative Colitis or Crohn\'s Disease)

Where it's recruiting

Arizona

Phoenix

Arkansas

Rogers

California

San Diego

Colorado

Aurora · Denver

Illinois

Chicago

Indiana

Indianapolis

Maryland

Bethesda

Minnesota

Rochester

New York

New York

North Carolina

Chapel Hill

Ohio

Cincinnati

Source: ClinicalTrials.gov · NCT02523118 · last updated 2025-09-12

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Acr · TrialPath